Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07447531) titled 'T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: John M. Buatti
Condition:
Malignant Glioma
Intervention:
Procedure: T2 (Observed)-Weighted Imaging
Procedure: Biospecimen Collection
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: October 3, 2025
Target Sample Size: 15
Countries of Recruitment:
United States
To know more, visi...